Trial Profile
Open Label Extension (OLE) for the Patients Treated in the ISD002-P144-07 Study With P144 Topical Adminsitration for Skin Fibrosis in Patients With Systemic Sclerosis [Extension of 700244348].
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 13 May 2014
Price :
$35
*
At a glance
- Drugs Disitertide (Primary)
- Indications Systemic scleroderma
- Focus Adverse reactions
- Sponsors Isdin
- 13 May 2014 New trial record